Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0368820220610030214
Journal of the Korean Neuropsychiatr Association
2022 Volume.61 No. 3 p.214 ~ p.223
Korean Medication Algorithm Project for Bipolar Disorder 2022: Maintenance Therapy
Lee Jung-Goo

Bahk Won-Myong
Woo Young-Sup
Jeong Jong-Hyun
Seo Jeong-Seok
Choo Il-Han
Yang Chan-Mo
Kim Won
Shim Se-Hoon
Jung Myung-Hun
Jon Duk-In
Park Sung-Yong
Sohn In-Ki
Kim Moon-Doo
Yoon Bo-Hyun
Abstract
Objectives : In this study, we investigated and organized the maintenance-treatment strategies for Bipolar I and II disorders outlined in The Korean Medication Algorithm Project for Bipolar disorder 2022 (KMAP-BP 2022).

Methods : The questionnaire sought to survey expert opinion on medication for bipolar disorders and was completed by a review committee consisting of 87 experienced Korean psychiatrists. It comprised 56 questions, and each question included various sub-items. The questionnaire for the maintenance treatments covered overall treatment strategies after acute mood episodes in bipolar I and II disorders, the choice of mood stabilizers and atypical antipsychotics and antidepressants, duration of medication, and treatment strategies for breakthrough symptoms.

Results : In the case of bipolar I disorder, mood stabilizer monotherapy, atypical antipsychoticsmonotherapy, and a combination of mood stabilizers and atypical antipsychotics were selectedas the first-line treatments. In maintenance management of bipolar II disorder, mood stabilizermonotherapy, atypical antipsychotics monotherapy, and combinations of mood stabilizers wereselected as the preferred first-line treatments.

Conclusion : There has been a growing body of evidence that atypical antipsychotics have agreater preference than observed in the previous KMAP-BP of 2018. Also, monotherapy ofmood stabilizers or atypical antipsychotics was more frequently selected in KMAP-BP 2022 thanin the KMAP-BP 2018.
KEYWORD
Bipolar disorder, KMAP-BP 2022, Maintenance therapy
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø